Ruth Simmons - Director, Pfizer Inc
As of April 28, 2006
Ruth Simmons Net Worth
- Net worth is estimated to be at least $27.61M
- Owns at least 1,200 units of Pfizer Inc stock
Ruth Simmons Trading
- Largest purchase of shares was 321 units , worth over $8.99K on November 18, 2004
- In total has made about 15 transactions over 3 years
- Usually trades in April, with the busiest year in 2004
RUTH SIMMONS
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Pfizer Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|
| A. Bourla | 2020 | $1,650,000 | - | $4,897,817 | $6,782,951 | $5,491,800 | $1,367,780 | $843,222 | $21,033,570 |
| A. Bourla | 2019 | $1,600,000 | - | $4,290,956 | $6,075,290 | $3,630,000 | $1,726,448 | $606,269 | $17,928,963 |
| A. Bourla | 2018 | $1,400,000 | - | $2,592,079 | $3,954,369 | $1,533,000 | $0 | $375,109 | $9,854,557 |
| F. D’Amelio | 2020 | $1,533,750 | - | $2,406,437 | $3,130,596 | $2,470,000 | $1,318,297 | $517,016 | $11,376,096 |
| F. D’Amelio | 2019 | $1,500,000 | - | $2,582,446 | $3,037,649 | $1,820,000 | $1,612,163 | $523,472 | $11,075,730 |
| F. D’Amelio | 2018 | $1,407,917 | - | $2,013,091 | $2,108,995 | $1,310,000 | $0 | $299,826 | $7,139,829 |
| M. Dolsten | 2020 | $1,433,750 | - | $2,110,585 | $2,608,832 | $2,600,000 | $928,638 | $467,819 | $10,149,624 |
| M. Dolsten | 2019 | $1,400,000 | - | $2,414,725 | $2,531,376 | $1,820,000 | $987,243 | $444,701 | $9,598,045 |
| M. Dolsten | 2018 | $1,306,250 | - | $2,013,091 | $2,108,995 | $1,326,000 | $0 | $315,863 | $7,070,199 |
| A. Hwang | 2020 | $1,142,500 | - | $1,420,129 | $2,087,062 | $2,387,800 | $405,242 | $440,714 | $7,883,447 |
| J. Young | 2020 | $1,285,000 | - | $1,814,734 | $2,087,062 | $1,800,000 | $1,551,403 | $450,994 | $8,989,193 |
| J. Young | 2019 | $1,245,000 | - | $2,247,004 | $2,025,093 | $1,675,000 | $1,325,847 | $441,439 | $8,959,383 |
| J. Young | 2018 | $1,206,250 | - | $2,013,091 | $2,108,995 | $1,385,000 | $0 | $408,379 | $7,121,715 |
| No matching records found | |||||||||
Source: https://www.sec.gov/Archives/edgar/data/78003/000007800321000047/proxystatement.htm
Pfizer Inc Insider Trading
- The most recent transaction was 40,000 units sold on November 30, 2021 by Douglas M Lankler worth over $2.17M
- In the last 18 years, insiders at Pfizer Inc sold an estimated value of $910.07M and bought an estimated value of $448.45M
- The most active traders are Loretta V Cangialosi, Sr. Vice President, Ian C Read, Executive Chairman, and Albert Bourla, Chairman & CEO
- Insider trading is most common in April, with the busiest year in 2013
PFIZER INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||